Promisia Healthcare Limited logo

Waiver from NZX Main Board Listing Rule 9.2.1

NZX Compliance5 November 2018PHLHealthcare

NZX Regulation Decision
Promisia Integrative Limited (PIL)

Application for a waiver from NZX Main Board Listing Rule

9.2.1(a)








2 November 2018













NZX REGULATION DECISION – 2 November 2018

2 of 5



Waiver from Listing Rules

Decision

1. Subject to the conditions set out in paragraph 2 below, and on the basis that the information

provided by PIL is complete and accurate in all material respects, NZXR grants PIL a waiver

from NZX Main Board Listing Rule 9.2.1 (

Rule

), to the extent that this Rule requires that PIL

seek shareholder approval to receive the Cash Advance from the Brankin Trust.

2. The waiver in paragraph 1 above is provided on the conditions that:

a. the non-interested Directors of PIL certify, in a form acceptable to NZXR, that:

i. There are no other viable sources of funding available to PIL.

ii. The Cash Advance is required urgently to provide PIL with working capital

so that PIL can continue to trade.

iii. The Cash Advance is being provided on terms that are more favourable

than any other funding option available to PIL.

iv. Receiving the Cash Advance is in the best interests of PIL and the

shareholders of PIL.

v. In deciding to accept the Cash Advance, the non-interested Directors of

PIL have not been unduly influenced by Mr Brankin or any Associated

Person of Mr Brankin.

vi. The certifying directors are not interested in the Cash Advance, as the

term is used in Rule 3.4.3, nor are they Associated Persons of Mr Brankin

or the Brankin Trust.

b. The Brankin Trust is providing the $440,000 Cash Advance on the basis there are

no immediate or on-call repayment obligations and zero percent interest for the

life of the loan. The key condition of providing the Cash Advance, other than

entering into the GSA, is that a resolution will be put to PIL shareholders seeking

approval for a transaction that will have the economic effect of repaying the Cash

Advance .

c. PIL will announce full details of the Cash Advance and loans with the Brankin

Trust to the market.

d. PIL will before 31 December 2018 seek shareholder approval in accordance with

Rule 9.2.1 for the method of repaying the Brankin Trust.

e. The waiver, its conditions and effect are disclosed to market and detailed in PIL’s

next annual report.

3. The information on which this decision is based is set out in Appendix One to this decision.

This waiver will not apply if that information is not or ceases to be full and accurate in all

material respects.

4. The Rules to which this decision relates are set out in Appendix Two to this decision.

5. Capitalised terms which have not been defined in this decision have the meanings given to

them in the Rules.



NZX REGULATION DECISION – 2 November 2018

3 of 5


Reasons

6. In coming to the decision to provide the waiver set out in paragraph 1 above, NZXR has

considered that:

a. Rule 9.2.1 seeks to regulate transactions where a Related Party to a Material

Transaction may gain favourable consideration due to their relationship with the Issuer.

NZXR may waive the requirement to obtain approval of a Material Transaction if it is

satisfied that involvement of any Related Party has not unduly influenced the promotion

of, or the decision to enter into, the transaction or its terms and conditions. NZXR is

satisfied that the granting of this waiver will not offend the policy behind Rule 9.2.1;

b. PIL has sought funding from a number of other sources but has not been able to secure

the additional working capital;

c. The Cash Advance is on better than commercial terms;

d. PIL has advised, and NZXR has no reason not to accept, that the Cash Advance will

provide PIL with urgent working capital and that without the Cash Advance PIL will not

be able to continue operating; and

e. The funds are required by PIL to meet its operating obligations prior to the earliest

practical time that a meeting of shareholders can be called.

Appendix One

1. Promisia Integrative Limited (

PIL

) is a Listed Issuer with ordinary shares Quoted on the NZX

Main Board and accordingly is subject to the NZX Main Board Listing Rules (

Rules

).

2. PIL has entered into an agreement to receive a $440,000 cash advance from the Brankin

Trust in instalments over a two-month period (the

Cash Advance

). PIL would ordinarily

require shareholder approval under Rule 9.2.1(a) for the Cash Advance as it will result in the

Brankin Trust lending PIL an amount in excess of 10% of PIL’s Average Market Capitalisation

which in accordance with Rule 9.2.2(c) is a Material Transaction. The Brankin Trust is an

Associated Person of Mr Brankin, a Director of PIL, and is therefore a Related Party of PIL

in accordance with Rule 9.2.3(c).

3. The terms of the Cash Advance are:

(a) Security is to be provided to the Brankin Trust by way of a General Security Agreement

(GSA) to the value of $1,500,000 charged over the assets of PIL;

(b) A resolution be placed before a meeting of shareholders as soon as practicable for

approval of a transaction that would have the economic effect of repaying the Cash

Advance will;

(c) There are no immediate or on-call repayment obligations for any portion of the Cash

Advance or other loans provided from the Brankin Trust;

(d) No interest is payable on the Cash Advance and

(e) The terms of the Cash Advance, including the open-ended repayment obligations, will

not change if PIL Shareholders do not approve Brankin Trust underwriting a potential

rights offer.

4. The GSA for $1,500,000 has already been entered into. This GSA covers an existing

$360,000 loan from the Brankin Trust, the intended $440,000 in additional Cash Advances,



NZX REGULATION DECISION – 2 November 2018

4 of 5


and a $798,175 debt assigned to the Brankin Trust as announced to the market on 5 October

2018.

5. PIL intends to conduct a rights offer of up to $2.3 million, with the Brankin Trust underwriting

up to $1.3 million of this offer (the

Rights Offer

). PIL intends to hold a shareholder meeting

at the end of November or early December to seek shareholder approval for the Brankin Trust

to underwrite the Rights Offer. Shareholder approval is required for the Brankin Trust to act

as an underwriter as the Brankin Trust is a Related Party of PIL in accordance with Rule

9.2.3(c).

6. If there is low shareholder uptake which results in the Brankin Trust supporting the offer in

accordance with the underwriting terms then it is possible the Brankin Trust will hold up to

68% of PIL’s issued share capital. PIL is engaging with the Takeovers Panel on the

application of the Takeovers Code to the Rights Offer.

7. PIL has submitted, and NZXR has no reason not to accept, that the Cash Advance will

provide PIL with urgent working capital and that without the Cash Advance PIL will not be

able to continue operating.



NZX REGULATION DECISION – 2 November 2018

5 of 5


Appendix Two


Rule 9.2 New Supply Arrangements with Related Parties

Rule 9.2.1 An Issuer shall not enter into a Material Transaction if a Related Party is, or is

likely to become:

(a) a direct or indirect party to the Material Transaction, or to at least one of a

related series of transactions of which the Material Transaction forms part;

or

...

unless that Material Transaction is approved by an Ordinary Resolution of the

Issuer.

Rule 3.4.3 Subject to Rule 3.4.3, a Director shall not vote on a Board resolution in respect of

any matter in which that Director is interested, nor shall the Director be counted in

the quorum for the purposes of consideration of that matter. For this purpose, the

term “interested” bears the meaning assigned to that term in section 139 of the

Companies Act 1993, on the basis that if an Issuer is not a company registered

under that Act, the reference to the “company” in that section shall be read as a

reference to the Issuer.

Rule 9.2.2 For the purposes of Rule 9.2.1, “Material Transaction” means a transaction or a

related series of transactions whereby an Issuer:

(c) borrows, lends, pays, or receives, money, or incurs an obligation, of an

amount in excess of 10% of the Average Market Capitalisation of the

Issuer; or ...

Rule 9.2.3 For the purposes of Rule 9.2.1, “Related Party” means a person who is at the time

of a Material Transaction, or was at any time within six months before a Material

Transaction:

(c) an Associated Person of the Issuer or any of the persons referred to in (a) or

(b), other than a person who becomes an Associated Person as a consequence

of the Material Transaction itself (or an intention or proposal to enter into the

Material Transaction itself); or

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.